-
INNOVATIVE GRAPH BASED CLUSTERING TO IDENTIFY SJÖGREN’S DISEASE SUBTYPES FROM REAL-WORLD DIAGNOSTIC JOURNEYS
Feb 25, 2026, 14:41 PM -
GENERATIVE ARTIFICIAL INTELLIGENCE FOR AUTOMATED HEALTH ECONOMIC MODEL DEVELOPMENT: A PROOF-OF-CONCEPT FRAMEWORK
Feb 25, 2026, 14:41 PM -
DEFINING VALUE IN ORTHOPEDICS: A COMPREHENSIVE REVIEW AND FRAMEWORK FOR DEVELOPING QUALITY AND COST METRICS
Feb 25, 2026, 14:41 PM -
FORECASTING THE DIALYSIS BURDEN IN MOROCCO AND THE ECONOMIC VALUE OF EARLY NEPHROPROTECTION : A 2025-2035 MARKOV-BASED MULTISCENARIO PROJECTION (PROMOD STUDY)
Feb 25, 2026, 14:41 PM -
ESTIMATING HETEROGENEOUS TREATMENT EFFECTS FOR PHARMACOEPIDEMIOLOGIC STUDIES: A SCOPING REVIEW FOR CAUSAL FOREST MODELS
Feb 25, 2026, 14:41 PM -
EVOLUTION OF PATIENT-REPORTED BURDEN AND UNMET NEEDS IN HEREDITARY ANGIOEDEMA: A COMPARATIVE SOCIAL MEDIA LISTENING ANALYSIS
Feb 25, 2026, 14:41 PM -
ACANTHOSIS NIGRICANS AS A CLINICAL MARKER FOR SCREENING OF POLYCYSTIC OVARY SYNDROME AMONG YOUNG WOMEN
Feb 25, 2026, 14:41 PM -
FACTORS ASSOCIATED WITH LONGITUDINAL TRAJECTORIES OF HYDROXYUREA ADHERENCE AMONG INDIVIDUALS WITH SICKLE CELL DISEASE: A GROUP-BASED TRAJECTORY MODELING STUDY
Feb 25, 2026, 14:41 PM -
A MOSAIC OF EVIDENCE: THE CLINICAL AND ECONOMIC BENEFITS OF CERAMIDE-INFUSED SKIN BARRIERS IN OSTOMY CARE
Feb 25, 2026, 14:41 PM -
PRACTICAL APPROACHES TO BUDGET IMPACT ANALYSIS IN HTA SYSTEMS: THE ROLE OF CLINICAL EXPERTS IN UKRAINE
Feb 25, 2026, 14:41 PM -
OVERVIEW OF THE EPIDEMIOLOGICAL AND ECONOMIC BURDEN OF CANCER IN THE MAGHREB
Feb 25, 2026, 14:41 PM -
INDIRECT TREATMENT COMPARISON OF TEPROTUMUMAB VS RITUXIMAB OR TOCILIZUMAB IN PATIENTS WITH MODERATE-TO-SEVERE ACTIVE THYROID EYE DISEASE
Feb 25, 2026, 14:41 PM -
ASSOCIATION BETWEEN CLINICAL MANIFESTATIONS OF GOUT AND PATIENT REPORTED OUTCOME MEASURES: RESULTS OF A REAL-WORLD SURVEY IN THE UNITED STATES
Feb 25, 2026, 14:41 PM -
USER EVALUATION OF AN AGENTIC AI ASSISTANT FOR REAL-WORLD EVIDENCE FEASIBILITY ANALYSIS
Feb 25, 2026, 14:41 PM -
NATIONWIDE PATHOLOGY SERVICES NETWORK STUDY ON DISINVESTMENT AND INVESTMENT STRATEGIES: A STUDY PROTOCOL
Feb 25, 2026, 14:41 PM -
COST PER CLINICAL WEIGHT-LOSS GOAL ACHIEVEMENT WITH SEMAGLUTIDE 2.4 MG VERSUS LIRAGLUTIDE 3 MG FROM A COLOMBIAN INSURER PERSPECTIVE
Feb 25, 2026, 14:41 PM -
SHAME, EMBARRASSMENT, AND THREATS TO DATA VALIDITY DUE TO CONFUSING COA WORDING: EXPLORATION OF CONCEPTUAL OVERLAP IN CRITICAL COA TERMINOLOGY IN THE CONTEXT OF GLOBAL ADMINISTRATION - FROM THE LINGUISTS’ PERSPECTIVE
Feb 25, 2026, 14:41 PM -
REAL-WORLD HEALTHCARE RESOURCE UTILIZATION AND ECONOMIC BURDEN OF NARCOLEPSY TYPE 1 IN THE US
Feb 25, 2026, 14:41 PM -
UTILIZATION OF GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS (GLP-1 RAS) FOR WEIGHT LOSS AND DIABETES: A STATE-LEVEL ANALYSIS ACROSS PAYER TYPES
Feb 25, 2026, 14:41 PM -
ACCELERATING EVIDENCE GENERATION: LEVERAGING LLMS FOR FULL-TEXT STUDY SELECTION
Feb 25, 2026, 14:41 PM
